Hereditary hemorrhagic telangiectasia: epistaxis and hemoptysis

Nanda, Sudip; Bhatt, Surya P.
April 2009
CMAJ: Canadian Medical Association Journal;4/14/2009, Vol. 180 Issue 8, p838
Academic Journal
The article presents a study about epistaxis and hemoptysis development. It highlights a case study of a 51-year-old woman with a history of perennial epistaxis which she acquired from her mother and sister. Diagnosis and long-term follow-up plan that the patient passed through in detection of the cause of the disease she had are indicated.


Related Articles

  • Pipamperone.  // Reactions Weekly;5/31/2008, Issue 1204, p26 

    The article describes the cases of 11 patients who experienced epistaxis after receiving pipamperone. Some patients also developed abdominal pain, headache, anorexia, pallor and several hematomas. Five of the patients had a positive outcome on dechallenge. One patient recovered after a reduction...

  • A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT). Zarrabeitia, Roberto; Albiñana, Virginia; Salcedo, Matilde; Señaris-Gonzalez, B.; Fernandez-Forcelledo, Jose-Luis; Botella, Luisa-Maria // Current Vascular Pharmacology;Jul2010, Vol. 8 Issue 4, p473 

    Hereditary Haemorrhagic Telangiectasia (HHT) or Rendu-Osler-Weber syndrome, is an autosomal dominant rare disease characterized by localized angiodysplasia. This is manifested as epistaxis, mucocutaneous and gastrointestinal telangiectases, and arteriovenous malformations in the pulmonary,...

  • Synthetic dural graft septoplasty in epistaxis from hereditary hemorrhagic telangiectasia. Burckhardt, Wilfred B.; Guerra, Claudia Patricia // Colombia Medica;Jul-Sep2013, Vol. 44 Issue 3, p189 

    It is an autosomal dominant vascular disorder, which has a variety of clinical manifestations, with epistaxis being one of the most common. Many treatment options exist for epistaxis, but with no consensus on which is the method of choice. We describe the case of a patient with hereditary...

  • Problemy w diagnostyce i leczeniu choroby Rendu-Oslera-Webera.  // Otorynolaryngologia;Dec2010, Vol. 9 Issue 4, p155 

    No abstract available.

  • Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire. Karapantzos, Ilias; Tsimpiris, Nikolaos; Goulis, Dimitrios G.; Van Hoecke, Helen; Van Cauwenberge, Paul; Danielides, Vasilis // European Archives of Oto-Rhino-Laryngology;Nov2005, Vol. 262 Issue 10, p830 

    The purpose of this study was to describe the results of Nd:YAG laser application in hereditary hemorrhagic telangiectasia (HHT) patients and to measure the Health-Related Quality of Life (HR-QoL) in patients with HHT before and after Nd:YAG laser application in a prospective, clinical trial at...

  • Antworten zu «Hereditäre hämorrhagische Teleangiektasie (Osler-Rendu-Syndrom) » aus PRAXIS Nr. 2.  // Praxis (16618157);1/30/2013, Vol. 102 Issue 3, p177 

    No abstract available.

  • The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia. Richer, Sara L.; Geisthoff, Urban W.; Livada, Nancy; Ward, P. Daniel; Johnson, Leland; Mainka, Alexander; Henderson, Katharine J.; Maune, Steffen; White Jr., Robert I.; Ross, Douglas A. // American Journal of Rhinology & Allergy;Sep/Oct2012, Vol. 26 Issue 5, p401 

    Background: Surgical treatment of epistaxis in hereditary hemorrhagic telangiectasia (HHT) has historically been managed with the laser procedure or the septodermoplasty procedure. For transfusion-dependent patients with severe epistaxis we have been performing the Young's procedure or surgical...

  • Treatment of epistaxis in hereditary hemorrhagic telangiectasia patients by argon plasma coagulation with local anesthesia. Pagella, Fabio; Semino, Lucia; Olivieri, Carla; Corno, Sabrina; Dore, Roberto; Draghi, Ferdinando; Lanzarini, Luca; Vespro, Valentina; Buscarini, Elisabetta; Danesino, Cesare // American Journal of Rhinology;Jul/Aug2006, Vol. 20 Issue 4, p421 

    Background: Recurrent epistaxis is the most common manifestation of hereditary hemorrhagic telangiectasia (HHT). The aim of this study was to determine the role and efficacy of argon plasma coagulation (APC) in the management of epistaxis caused by HHT. Methods: From 1997 to 2004, 43 patients...

  • First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT). Al Kadah, Basel; Papaspyrou, George; Schneider, Mathias; Schick, Bernhard // European Archives of Oto-Rhino-Laryngology;Jan2015, Vol. 272 Issue 1, p117 

    Hereditary haemorrhagic teleangiectasia (HHT) is most notably characterized by vulnerable vascular formations of the nasal superficial mucosa. Epistaxis is one of the most common symptoms of the afflicted patients, with an incidence of more than 90 %. A variable series of treatments have been...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics